Mortimer Mamelak, University of Toronto

Research

Read how they describe their research on their University of Toronto profile.

Latest papers

Can Sodium Oxybate Mitigate the Symptoms of Schizophrenia?
Current neuropharmacology · 2026 · first author
The Alzheimer's Disease Brain, Its Microvasculature, and NADPH Oxidase.
Journal of Alzheimer's disease : JAD · 2024 · first author
Depression and the Glutamate/GABA-Glutamine Cycle.
Current neuropharmacology · 2024 · first author

All 15 publications

15 publications.

01

Can Sodium Oxybate Mitigate the Symptoms of Schizophrenia?

Mamelak M

Current neuropharmacology2026First author

DOI: 10.2174/011570159x377481250526110256 PMID: 40468931

02

The Alzheimer's Disease Brain, Its Microvasculature, and NADPH Oxidase.

Mamelak M

Journal of Alzheimer's disease : JAD2024First author

DOI: 10.3233/jad-230415 PMID: 37599534

03

Depression and the Glutamate/GABA-Glutamine Cycle.

Mamelak M

Current neuropharmacology2024First author

DOI: 10.2174/1570159x22666240815120244 PMID: 39150032

04

The Treatment of Parkinson's Disease with Sodium Oxybate.

Mamelak M

Current molecular pharmacology2023First author

DOI: 10.2174/1874467216666221103121135 PMID: 36330625

05

Prevention of Lipotoxicity in Pancreatic Islets with Gammahydroxybutyrate.

Yung JHM, Yeung LSN, Ivovic A, Tan YF, Jentz EM, Batchuluun B, Gohil H, Wheeler MB, Joseph JW, Giacca A, Mamelak M

Cells20226 citationsSenior authorOpen Access

DOI: 10.3390/cells11030545 PMID: 35159354

06

Sleep, Narcolepsy, and Sodium Oxybate.

Mamelak M

Current neuropharmacology2022First author

DOI: 10.2174/1570159x19666210407151227 PMID: 33827411

07

Nightmares and the Cannabinoids.

Mamelak M

Current neuropharmacology2020First author

DOI: 10.2174/1570159x18666200114142321 PMID: 31934840

08

Parkinson's Disease, the Dopaminergic Neuron and Gammahydroxybutyrate.

Mamelak M

Neurology and therapy2018First author

DOI: 10.1007/s40120-018-0091-2 PMID: 29368093

09

Correlation of Changes in Patient-Reported Quality of Life With Physician-Rated Global Impression of Change in Patients With Narcolepsy Participating in a Clinical Trial of Sodium Oxybate: A Post Hoc Analysis

Richard Bogan, Jed E. Black, Todd J. Swick, Mortimer Mamelak, Ružica Kovačević-Ristanović, Kathleen F. Villa, Fannie Mori, Jacques Yves Montplaisir

Neurology and Therapy201710 citationsOpen Access

DOI: 10.1007/s40120-017-0076-6 PMID: 28707076

10

Energy and the Alzheimer brain.

Mamelak M

Neuroscience and biobehavioral reviews2017First author

DOI: 10.1016/j.neubiorev.2017.02.001 PMID: 28193453

Frequent collaborators

Department of Psychiatry
Department of Medicine
School of Pharmacy
Department of Physiology

Co-authors at University of Toronto, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.

Jacques Montplaisir

Centre d'étude du sommeil

3 shared papers, latest 2017

Adria Giacca

Department of Medicine

1 shared papers, latest 2022

Michael Wheeler

Department of Physiology

1 shared papers, latest 2022

Jamie Joseph

School of Pharmacy

1 shared papers, latest 2022

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mention

Subject: Prospective PhD student Dear Professor Mamelak, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Can Sodium Oxybate Mitigate the Symptoms of Schizophrenia?" (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]